Lyra Therapeutics Inc
LYRA
Market Cap$19.88M
Close$
$-1.65
599.3% downside
Current Fair Value
599.3% downsideOvervalued by 599.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $19.88 Million |
|---|---|
| Enterprise Value | $-29,377,359.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.22 |
| Beta | -0.1 |
| Outstanding Shares | 60,964,859 |
| Avg 30 Day Volume | 8,565,302 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.29 |
|---|---|
| PEG | -0.76 |
| Price to Sales | - |
| Price to Book Ratio | 0.33 |
| Enterprise Value to Revenue | -17.49 |
| Enterprise Value to EBIT | 0.41 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.29 |
| Debt to Equity | 0.49 |
Revenue Sources
No data
Insider Trades
ESG Score
No data